XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.70

-0.8%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William L. Molair II who wrote (9141)	3/11/1999 9:13:00 PM
From: aknahow	Read Replies (1) of 17367

<Also, seems to me that DSMB would have stopped the trial a long time ago if there were not any mengio deaths in the group of children taking Neuprex.> Yes, I agree, except that after reading the Robert_S post on the DSMB on the importance of meeting all the FDA conditions, I am no longer sure they could recommend stopping if the target not reached. This does not mean I believe everyone in the treatment group survived. He was also very bullish on CORR and had details that I thought would appear elsewhere but so far have not. I wonder if they were correct. The market action of CORR indicates it was not impressed. I wish he would get his details straight.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next